enGene Therapeutics (ENGN) Non Operating Income (2023 - 2026)
enGene Therapeutics (ENGN) recorded Non Operating Income of $1.51 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 26.6% from $1.2 million a year earlier but down 13.1% from the prior quarter.
enGene Therapeutics (ENGN) Non Operating Income (2023 - 2026) Analysis & Trends
On a TTM basis, enGene Therapeutics' Non Operating Income came in at $5.79 million as of Jul 31, 2026, down 16.5% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $5.86 million, down 17.8% from FY2024.
- Across earlier fiscal years, Non Operating Income came in at $7.14 million in FY2024, -$73.84 million in FY2023 and -$5.01 million in FY2022.
- Quarterly Non Operating Income has ranged from -$72.04 million in fiscal Q4 2023 to $2.58 million in fiscal Q3 2024 over the past five years.
- On a year-over-year basis, Non Operating Income rose in two of the last six quarters, with an average decline of 21.1%.
- Per Business Quant, the preceding three fiscal quarters came in at $1.74 million (Q2 2026), $1.43 million (Q1 2026) and $1.1 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 1.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.51 Mn |
| Apr 30, 2026 | 1.74 Mn |
| Jan 31, 2026 | 1.43 Mn |
| Oct 31, 2025 | 1.10 Mn |
| Jul 31, 2025 | 1.20 Mn |
| Apr 30, 2025 | 1.55 Mn |
| Jan 31, 2025 | 2.02 Mn |
| Oct 31, 2024 | 2.18 Mn |
| Jul 31, 2024 | 2.58 Mn |
| Apr 30, 2024 | 2.35 Mn |
| Jan 31, 2024 | 32,000.00 |
| Oct 31, 2023 | -72.04 Mn |
| Jul 31, 2023 | 1.53 Mn |
| Apr 30, 2023 | -545,000.00 |
| Jan 31, 2023 | -2.79 Mn |
enGene Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();